News for Applied Therapeutics, Inc. (APLT)

Evan Bailey, MD, promoted to Chief Medical Officer, succeeding Riccardo Perfetti, MD, PhDDottie Caplan promoted to Executive Vice President, Patient Advocacy an

Applied Therapeutics (APLT) has made significant leadership changes, elevating Evan Bailey to the position of chief medical officer, effective June 15. In his n

Applied Therapeutics (APLT) revealed comprehensive 12-month clinical findings alongside fresh 18 and 24-month topline data from the INSPIRE Phase 2/3 trial duri

Slowing of progression of disease observed via MRI at 24 monthsImprovements in outcomes and reduction in sorbitol maintained through 24 monthsSta...

On May 14, 2025, RBC Capital analyst Brian Abrahams reiterated his rating on Applied Therapeutics (APLT), maintaining a "Sector Perform" designation. This refle

As of March 31, Applied Therapeutics (APLT) reported cash and cash equivalents alongside short-term investments amounting to $50.8 million, a decrease from $79.

- Company to present full 12-month clinical data and new topline 18-month and 24-month data from INSPIRE registrational Phase 3 trial of govorestat in CMT-SORD

**media[620853]**

Applied Therapeutics (APLT) announced its financial results for fiscal year 2024, revealing a revenue of $455,000, which fell short of market expectations of $5

**media[594969]**

Dr. Baumgartner will advance Applied's preparation for upcoming regulatory interactions NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, I

**media[570620]**

LOS ANGELES, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shar

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied The

NEW YORK, Feb. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics

PR NewswireSAN DIEGO, Feb. 17, 2025 SAN DIEGO, Feb. 17, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or

PR NewswireNEW YORK, Feb. 16, 2025 NEW YORK, Feb. 16, 2025 /PRNewswire/ --

NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied The

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of Applied Therapeutics, I